Dr. Maude focuses on novel therapies for high-risk and relapsed pediatric acute lymphoblastic leukemia (ALL). She aims to identify new pediatric ALL treatments that are more effective, less toxic, and exhibit fewer side effects than existing cancer therapies.

Professional Awards
American Society of Hematology Abstract Achievement Award, 2011
American Society of Pediatric Hematology/Oncology Young Investigator Travel Stipend Award, 2012
St. Baldrick's Foundation Scholar Award, 2013
International Society of Paediatric Oncology Young Investigator Award, 2014
Forbeck Foundation Scholar, 2015